neuroClues

NeuroClues® is a revolutionary medical technology that leverages eye-tracking to provide instant, quantifiable insights during clinical examinations. By using eye movements as biomarkers, this cutting-edge solution aims to transform the diagnosis and management of neurological conditions. NeuroClues® offers a non-invasive, efficient way to assess brain health, detecting subtle changes that may indicate early stages of neurological diseases or monitor the progression of existing conditions, thereby facilitating timely decision-making in treatment plans.

The technology operates by analyzing eye movements, which are controlled by various brain regions, making them a window into the central nervous system's health. This approach not only ensures patient comfort by avoiding invasive procedures but also provides reliable data swiftly, aiding in the advancement of neurological research with its detailed analysis capabilities.

NeuroClues® is designed to enhance diagnosis and patient care through early disease detection, objective progress tracking, and serving as a high-resolution research tool. Its potential applications span various aspects of neurological care and research, including Parkinson’s Disease, Alzheimer’s Disease, concussion assessment, and academic and clinical research.